| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 7,890 | 5,508 | 6,038 | 7,688 | | Cost of Revenue | 5,923 | 4,157 | 5,515 | 5,063 | | | Gross Profit | 1,967 | 1,351 | 523 | 2,625 | | | Operating Expenses | | Research Development | 19,201 | 21,312 | 20,030 | 23,709 | | Selling General and Administrative | 4,213 | 4,585 | 4,461 | 4,482 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (21,447) | (24,546) | (23,968) | (25,566) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 87 | 293 | (2,970) | (9,917) | | Earnings Before Interest And Taxes | (21,360) | (24,253) | (26,938) | (35,483) | | Interest Expense | 3,442 | 2,735 | 2,673 | 2,336 | | Income Before Tax | (24,802) | (26,988) | (29,611) | (37,819) | | Income Tax Expense |
-
| (288) |
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (24,802) | (26,700) | (29,611) | (37,819) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (24,802) | (26,700) | (29,611) | (37,819) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($24,802) | ($26,700) | ($29,611) | ($37,819) |
|
0.11% Nasdaq 0.00%
Income Statement
